tiprankstipranks
Basilea Pharmaceutica (CH:BSLN)
:BSLN
Switzerland Market
Want to see CH:BSLN full AI Analyst Report?

Basilea Pharmaceutica (BSLN) Technical Analysis

7 Followers

Summary of all the Indicators

Overall Consensus
Sell
6Bullish
4Neutral
12Bearish
Technical Analysis Consensus
Buy
4Bullish
4Neutral
2Bearish
Moving Average Consensus
Strong Sell
2Bullish
0Neutral
10Bearish
Basilea Pharmaceutica’s (BSLN) Moving Averages Convergence Divergence (MACD) indicator is -0.39, suggesting Basilea Pharmaceutica is a Buy.
Basilea Pharmaceutica’s (BSLN) 20-Day exponential moving average is 53.71, while Basilea Pharmaceutica’s (BSLN) share price is CHF52.6, making it a Sell.
Basilea Pharmaceutica’s (BSLN) 50-Day exponential moving average is 53.89, while Basilea Pharmaceutica’s (BSLN) share price is CHF52.6, making it a Sell.

Basilea Pharmaceutica (BSLN) Pivot Points

May 30, 2026, 07:20 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
49.33
50.37
51.43
52.47
53.53
54.57
55.63
Fibonacci
50.37
51.17
51.66
52.47
53.27
53.76
54.57
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Basilea Pharmaceutica (BSLN) Moving Averages

May 30, 2026, 07:20 AM
Period
Simple
Exponential
MA5
53.00Sell
52.85Sell
MA10
53.38Sell
53.30Sell
MA20
54.01Sell
53.71Sell
MA50
53.75Sell
53.89Sell
MA100
54.29Sell
53.49Sell
MA200
51.43Buy
51.94Buy
Basilea Pharmaceutica’s (BSLN) 10-Day exponential moving average is 53.30, while Basilea Pharmaceutica’s (BSLN) share price is CHF52.6, making it a Sell.
Basilea Pharmaceutica’s (BSLN) 100-Day exponential moving average is 53.49, while Basilea Pharmaceutica’s (BSLN) share price is CHF52.6, making it a Sell.
Basilea Pharmaceutica’s (BSLN) stock price is CHF52.6 and Basilea Pharmaceutica’s (BSLN) 50-day simple moving average is 53.75, creating a Sell signal.
Basilea Pharmaceutica’s (BSLN) stock price is CHF52.6 and Basilea Pharmaceutica’s (BSLN) 100-day simple moving average is 54.29, creating a Sell signal.
Basilea Pharmaceutica’s (BSLN) stock price is CHF52.6 and Basilea Pharmaceutica’s (BSLN) 200-day simple moving average is 51.43, creating a Buy signal.

Basilea Pharmaceutica (BSLN) Technical Indicators

May 30, 2026, 07:20 AM
Name
Value
Implied Action
RSI (14)
37.66
Neutral
STOCH (9,6)
23.59
Neutral
STOCHRSI (14)
21.02
Neutral
MACD (12,26)
-0.39
Buy
ADX (14)
13.69
Buy
Williams %R
-85.71
Buy
CCI (14)
-158.43
Buy
ATR (14)
1.40
-
Ultimate Oscillator
45.34
Neutral
ROC
-4.40
Sell
Basilea Pharmaceutica’s (BSLN) Relative Strength Index (RSI) is 37.66, creating a Neutral signal.
Basilea Pharmaceutica’s (BSLN) Trend Strength Indicator (ADX) is 13.69, creating a Buy signal.
Basilea Pharmaceutica’s (BSLN) Commodity Channel Index (CCI) is -158.43, creating a Buy signal.
Basilea Pharmaceutica’s (BSLN) Price Rate of Change (ROC) is -4.40, creating a Sell signal.

FAQ

Is BSLN a Buy, Hold, or Sell?
Based on BSLN’s technical indicators, BSLN is a Sell.
    What is BSLN’s RSI (14)?
    BSLN’s RSI (14) is 37.66, which suggests BSLN is a Neutral.
      What is BSLN’s MACD?
      BSLN’s MACD is -0.39, which suggests BSLN is a Buy.
        What is BSLN’s 5-day moving average?
        BSLN’s 5-day moving average is 53.00, which suggests BSLN is a Sell.
          What is BSLN’s 20-day moving average?
          BSLN 20-day moving average is 54.01, which suggests BSLN is a Sell.
            What is BSLN’s 50-day moving average?
            BSLN’s 50-day moving average is 53.75, which suggests BSLN is a Sell.
              What is BSLN’s 200-day moving average?
              BSLN’s 200-day moving average is 51.43, which suggests BSLN is a Buy.
                What is BSLN’s Williams % R (14)?
                BSLN’s Williams % R (14) is -85.71, which suggests BSLN is a Buy.
                  What is BSLN’s CCI (14)?
                  BSLN’s CCI (14) is -158.43, which suggests BSLN is a Buy.
                    What is the share price of Basilea Pharmaceutica?